Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Shares Issued: 2013-2025

Historic Shares Issued for Abeona Therapeutics (ABEO) over the last 5 years, with Jun 2025 value amounting to $10.5 million.

  • Abeona Therapeutics' Shares Issued fell 83.52% to $10.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $26.4 million, marking a year-over-year decrease of 69.53%. This contributed to the annual value of $15.5 million for FY2024, which is 32.66% down from last year.
  • Abeona Therapeutics' Shares Issued amounted to $10.5 million in Q2 2025, which was up 54.45% from $6.8 million recorded in Q1 2025.
  • In the past 5 years, Abeona Therapeutics' Shares Issued registered a high of $63.7 million during Q2 2024, and its lowest value of -$54.7 million during Q4 2024.
  • In the last 3 years, Abeona Therapeutics' Shares Issued had a median value of $6.8 million in 2025 and averaged $7.0 million.
  • As far as peak fluctuations go, Abeona Therapeutics' Shares Issued spiked by 17,500.00% in 2021, and later tumbled by 5,467,900.00% in 2024.
  • Over the past 5 years, Abeona Therapeutics' Shares Issued (Quarterly) stood at $352,000 in 2021, then soared by 7,971.31% to $28.4 million in 2022, then plummeted by 100.00% to $1,000 in 2023, then plummeted by 5,467,900.00% to -$54.7 million in 2024, then tumbled by 83.52% to $10.5 million in 2025.
  • Its last three reported values are $10.5 million in Q2 2025, $6.8 million for Q1 2025, and -$54.7 million during Q4 2024.